Search
SOLACI Congress
HomeFile

File

View Category
Coronary disease

Coronary Events Following TAVI: A Registry

Between 30 and 70% of patients undergoing transcatheter aortic valve replacement (TAVR) present coronary artery disease (CAD)....
Dr. Andrés Rodríguez -
Learn More
Other

Transcatheter Treatment with EVOQUE: First Real-World Results

Severe tricuspid regurgitation (TR) has historically been underestimated due to its poor prognosis and the limited benefit...
Dr. Omar Tupayachi -
Learn More
Peripheral vascular disease

Renal Denervation and SPYRAL HTN-ON MED Two-Year Outcomes

High blood pressure (BP) continues to be one of the leading preventable causes of cardiovascular events worldwide....
Dr. Omar Tupayachi -
Learn More
Chronic Coronary Syndromes

Variability of Coronary Physiology (FFR/iFR) in Diffuse Tandem Lesions

Physiology guided revascularization has been shown to improve clinical outcomes vs. conventional angiography. However, after percutaneous coronary...
Dr. Omar Tupayachi -
Learn More
Structural heart disease

NAVULTRA Registry: One-Year Outcomes of Self-Expanding vs. Balloon-Expandable Valves

In recent years, technological advances and increased operator experience have significantly contributed to improve transcatheter aortic valve...
Dr. Andrés Rodríguez -
Learn More
Structural heart disease

RHEIA Study: TAVR vs. SAVR for Severe Aortic Stenosis in Women

Severe aortic stenosis in women presents several differences compared to men, such as smaller aortic annuli, greater...
Dr. Carlos Fava -
Learn More
Femoropopliteal

Post-Rotational Atherectomy Imaging in Femoropopliteal Lesions (INSIGHT-JETSTREAM)

Severely calcified femoropopliteal disease represents a significant clinical challenge, particularly concerning adequate lesion preparation before the implantation...
Dr. Omar Tupayachi -
Learn More
Structural heart disease

TAVR in Women

Severe aortic stenosis (AS) in women shows distinct features, compared to men, with lower prevalence of heart...
Dr. Carlos Fava -
Learn More

SOLACI is the reference organization for Latin American cardiovascular interventionism.

Last News

Transcatheter Deep Vein Arterialization in Critical Limb Ischemia Without Revascularization Options

Dr. Juan Manuel Pérez - 0
Chronic limb-threatening ischemia in patients without conventional revascularization options represents one of the most challenging scenarios within peripheral arterial disease, with 1-year major amputation...

Transcatheter Paravalvular Leak Closure: Mid-Term Outcomes and Prognostic Factors

Dr. Andrés Rodríguez - 0
Paravalvular leaks (PVL) are a frequent complication following surgical valve replacement, occurring in 5% to 18% of prosthetic valves. Incidence varies according to valve...

After a Major Bleeding Event in Atrial Fibrillation: When Should Left Atrial Appendage Closure Be Considered?

Dr. Juan Manuel Pérez - 0
Atrial fibrillation (AF) in patients who experience a major bleeding event represents a complex clinical scenario in which percutaneous left atrial appendage closure (LAAC)...

Institutional News

Fellow’s Corner 2026 – Submit Your Clinical Case

solaci - 0
Share your experience. Learn from experts. Grow as an interventional cardiologist. The Latin American Society of Interventional Cardiology (SOLACI) is relaunching this year the Fellow’s...

Watch Again: Cardiovascular Risk Factors in Women | SOLACI Technicians Webinar

solaci - 0
The webinar “Cardiovascular Risk Factors in Women,” held on January 27, 2026, via the Zoom platform, is now available for viewing on SOLACI’s YouTube...

Technical Training in Hemodynamics and Interventional Cardioangiology | SOLACI–CACI

solaci - 0
The SOLACI–CACI Technical Training in Hemodynamics and Interventional Cardioangiology is an academic program designed for the initial training and professional development of non-physician healthcare...

Access

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use -Privacy Policy